Treatment Strategies for Antibody-mediated Rejection in Kidney Transplantation and Its Prevention
Abstract
Open Access
ISSN 2577-5820
© 2020 by the authors; CC BY 4.0 licence
OBM Transplantation , Volume 4 , Issue 3 (2020)
Pages: 75
Published: October 2020
(This book is a printed edition that was published in OBM Transplantation)
Cover story: Dutton et al. describe a first technology for specific quantification of the dosage of tissue stem cells in transplantation medicine. Current treatments like cord blood stem cells occur without knowing the dose. The report describes specific counting algorithms with potential to provide this long unavailable information for stem cell transplantation medicine. View this paper.
Volume 4,Issue 3
Treatment Strategies for Antibody-mediated Rejection in Kidney Transplantation and Its PreventionAbstract This article reviews the current treatment strategies of antibody-mediated rejection in kidney transplantation, which is increasingly recognized as the leading immunological cause of graft failure. The pathophysiologic complexity of this condition poses significant challenges for its treatment; however, progress toward advancing our understanding of its pathogenesis and diagnosis will allow for identification of new therapeutic targets. Emphasis is also given to prevention, which is mainly based [...] |
Severe Hypercholesterolemia Associated with Steroid-Refractory Acute Liver GVHD: Unusual Complication of Allogeneic Hematopoietic Cell TransplantationAbstract Severe hypercholesterolemia is an uncommon complication of allogenic hematopoietic cell transplantation (HCT). Treatment options for hypercholesterolemia due to liver graft-versus-host disease (GVHD) are limited because many antilipidemic medications are known to worsen hepatic functions. We report our experience on a case of a 38-year-old male with Philadelphia chromosome positive acute lymphoblastic leukemia presenting with steroid-refractory hepatic and lower gastrointestinal acute GVHD after [...] |
A Computational Simulation Technology for Specific Counting of Perinatal and Postnatal Human Tissue Stem Cells for Transplantation MedicineAbstract Although tissue stem cells are essential for the maintenance, renewal, and repair of vertebrate organs and tissues, previously, the simple act of counting them has not been possible. For more than a half-century, progress in tissue stem cell research and medicine has been undermined by the lack of a means to determine tissue stem cell number. In particular, a major unmet need for stem cell transplantation medicine has been a way to quantify the specific dosage of tissue stem cell treatments. The [...] |
The Use of ECMO in Treatment of Post Liver Transplant Septic ShockAbstract Liver transplant is a life-saving therapy for patients with end stage liver disease and liver cancer. Liver re-transplantation cases are usually more challenging and riskier than primary surgery, they require careful consideration and larger recourse utilization. Decision making on who receives transplantation surgery includes individual patient risks and benefits, physician judgment, specific transplant center policies, surgical experience, geographic organ availability, and ethical considerati [...] |
Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomesby
Khawla F. Ali
and
Betul Hatipoglu
Abstract Pancreatic islet transplantation is a rapidly evolving field. It has been increasingly regarded as a promising approach for the correction of dysglycemia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of surgical diabetes in chronic pancreatitis subjects undergoing total pancreatectomy (autologous islet transplantation). In this review, we discuss the latest literature pertaining to metabolic outcomes of autologous and allogenic islet transplantatio [...] |
Single-Center Outcomes of Heart Transplantation in Patients with Pulmonary Hypertension Bridged with Mechanical Circulatory Supportby
Dominic Emerson
,
Jon Kobashigawa
,
Ryan Levine
,
Jamie Moriguchi
,
Dominick Megna
,
Joshua Chung
,
Dany Ramzy
,
Alfredo Trento
and
Fardad Esmailian
Abstract In advanced heart failure, orthotopic heart transplantation (OHT) remains the standard for definitive treatment. Patients with heart failure and concomitant pulmonary hypertension (PH) represent a challenging subgroup, with poor outcomes following OHT. Recently, Mechanical Circulatory Support (MCS) devices have been utilized as a bridge to OHT for these patients. Patients with MCS devices who underwent OHT were evaluated at a single center. Patients were stratified into three groups, depending o [...] |
TOP